AAAAAA

   
Results: 1-11 |
Results: 11
QUANTITATIVE MEASURES ARE MORE SENSITIVE TO WORSENING NEUROLOGICAL FUNCTION IN A PROSPECTIVE MULTIPLE-SCLEROSIS STUDY
Authors: SCHWID SR GOODMAN AD APATOFF BR COYLE PK JACOBS LD KRUP LB MILLER AE WENDE K
Citation: Sr. Schwid et al., QUANTITATIVE MEASURES ARE MORE SENSITIVE TO WORSENING NEUROLOGICAL FUNCTION IN A PROSPECTIVE MULTIPLE-SCLEROSIS STUDY, Annals of neurology, 44(3), 1998, pp. 163-163
QUANTITATIVE MEASURES OF MOTOR FATIGUE IN MULTIPLE-SCLEROSIS - FEATURES OF MOTOR DYSFUNCTION DISTINCT FROM WEAKNESS
Authors: SCHWID SR THORNTON CA GOODMAN AD PANDYA S MANZUR KL PETRIE MD MCDERMOTT MP
Citation: Sr. Schwid et al., QUANTITATIVE MEASURES OF MOTOR FATIGUE IN MULTIPLE-SCLEROSIS - FEATURES OF MOTOR DYSFUNCTION DISTINCT FROM WEAKNESS, Neurology, 50(4), 1998, pp. 4036-4036
THE CAUSE OF OSTEOPOROSIS IN MULTIPLE-SCLEROSIS
Authors: SCHWID SR GOODMAN AD MATTSON DH
Citation: Sr. Schwid et al., THE CAUSE OF OSTEOPOROSIS IN MULTIPLE-SCLEROSIS, Annals of neurology, 42(3), 1997, pp. 119-119
NEUROPSYCHOLOGICAL STATUS IN PATIENTS WITH MULTIPLE-SCLEROSIS AFTER TREATMENT WITH COPOLYMER-1
Authors: WEINSTEIN A SCHWID SR SCHIFFER RB MCDERMOTT MP GIANG DW GOODMAN AD LINDA L
Citation: A. Weinstein et al., NEUROPSYCHOLOGICAL STATUS IN PATIENTS WITH MULTIPLE-SCLEROSIS AFTER TREATMENT WITH COPOLYMER-1, Annals of neurology, 42(3), 1997, pp. 263-263
THE MEASUREMENT OF AMBULATORY IMPAIRMENT IN MULTIPLE-SCLEROSIS
Authors: SCHWID SR GOODMAN AD MATTSON DH MIHAI C DONOHOE KM PETRIE MD SCHEID EA DUDMAN JT MCDERMOTT MP
Citation: Sr. Schwid et al., THE MEASUREMENT OF AMBULATORY IMPAIRMENT IN MULTIPLE-SCLEROSIS, Neurology, 49(5), 1997, pp. 1419-1424
QUANTITATIVE ASSESSMENT OF SUSTAINED-RELEASE 4-AMINOPYRIDINE FOR SYMPTOMATIC TREATMENT OF MULTIPLE-SCLEROSIS
Authors: SCHWID SR PETRIE MD MCDERMOTT MP TIERNEY DS MASON DH GOODMAN AD
Citation: Sr. Schwid et al., QUANTITATIVE ASSESSMENT OF SUSTAINED-RELEASE 4-AMINOPYRIDINE FOR SYMPTOMATIC TREATMENT OF MULTIPLE-SCLEROSIS, Neurology, 48(4), 1997, pp. 817-821
MEASUREMENT OF AMBULATORY FUNCTION IN MULTIPLE-SCLEROSIS
Authors: SCHWID SR GOODMAN AD MATTSON DH MIHAI C DONOHOE KM PETRIE MD SCHEID EA DUDMAN JT
Citation: Sr. Schwid et al., MEASUREMENT OF AMBULATORY FUNCTION IN MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 3073-3073
SELECTION CRITERIA FOR INTERFERON BETA-1B IN MULTIPLE-SCLEROSIS PATIENTS
Authors: MIHAI C SCHWID SR PETRIE MD GOODMAN AD MATTSON DH
Citation: C. Mihai et al., SELECTION CRITERIA FOR INTERFERON BETA-1B IN MULTIPLE-SCLEROSIS PATIENTS, Neurology, 48(3), 1997, pp. 48005-48005
AUTOIMMUNE HYPERTHYROIDISM IN PATIENTS WITH MULTIPLE-SCLEROSIS TREATED WITH INTERFERON BETA-1B
Authors: SCHWID SR GOODMAN AD MATTSON DH
Citation: Sr. Schwid et al., AUTOIMMUNE HYPERTHYROIDISM IN PATIENTS WITH MULTIPLE-SCLEROSIS TREATED WITH INTERFERON BETA-1B, Archives of neurology, 54(9), 1997, pp. 1169-1170
SPORADIC CORTICOSTEROID PULSES AND OSTEOPOROSIS IN MULTIPLE-SCLEROSIS
Authors: SCHWID SR GOODMAN AD PUZAS JE MCDERMOTT MP MATTSON DH
Citation: Sr. Schwid et al., SPORADIC CORTICOSTEROID PULSES AND OSTEOPOROSIS IN MULTIPLE-SCLEROSIS, Archives of neurology, 53(8), 1996, pp. 753-757
THE EFFECT OF CORTICOSTEROID PULSES ON BONE-DENSITY IN MULTIPLE-SCLEROSIS
Authors: SCHWID SR GOODMAN AD MATTSON DH
Citation: Sr. Schwid et al., THE EFFECT OF CORTICOSTEROID PULSES ON BONE-DENSITY IN MULTIPLE-SCLEROSIS, Annals of neurology, 38(2), 1995, pp. 338-339
Risultati: 1-11 |